A decade of health innovation: the impact of new medicines on patient health and the implications for NICE’s size of benefit multiplier

6 October 2023 - This study aimed to estimate the incremental health benefits of pharmaceutical innovations approved between 2011 and 2021 ...

Read more →

Bayer shifts pharma focus away from ‘innovation unfriendly’ Europe

16 January 2023 - Bayer has said it is shifting the focus of its pharmaceutical business to the US and ...

Read more →

NICE’s new methods: putting innovation first, but at what cost?

28 November 2022 - Traditionally the gatekeeper to the NHS, NICE has increasingly reoriented its role towards facilitating access to innovative ...

Read more →

The Innovative Medicines Fund - good news for patients but has an opportunity been missed to be more ambitious?

27 June 2022 - NHS England and Improvement has announced the launch of the Innovative Medicines Fund. The ABPI’s Director ...

Read more →

Shionogi signs agreement with NHS England to begin an innovative subscription payment model for reimbursement of its antibiotic, Fetcroja (cefiderocol)

15 June 2022 - Shionogi recognises the UK’s leadership role in introducing the world’s first fully ‘delinked’ pilot reimbursement model; pull ...

Read more →

England’s Innovative Medicines Fund hits another milestone

15 June 2022 - Just like the Cancer Drugs Fund, the time-limited fund for the most promising cancer drugs introduced ...

Read more →

NHS England unveils new Innovative Medicine Fund

21 July 2021 - NHS England has unveiled its new Innovative Medicines Fund, to ensure patients have early access to ...

Read more →

NICE launches ambitious strategy to provide quicker access to new treatments and innovations

19 April 2021 - NICE will transform key elements of its approach to ensure efficiency and speed while maintaining robust, trusted ...

Read more →

NICE methods and process review aims to create fertile ground for innovation

29 March 2021 - The way NICE reviews new medicines is about to go through its biggest change in years – ...

Read more →

On the integration of early health technology assessment in the innovation process: reflections from five stakeholders

28 October 2020 - Early health technology assessment, which includes all methods used to inform industry and other stakeholders about the ...

Read more →

Evidence for HTA: innovative methods for challenging times

13 October 2020 - Dalia Dawoud, Scientific Adviser at NICE Science, Evidence and Analytics Directorate explains NICE’s role as co-host of ...

Read more →

After 20 years of using economic evaluation, should NICE be considered a methods innovator?

13 January 2020 - NICE is only one of several organisations internationally that uses economic evaluation as part of decision ...

Read more →

Closing the cycle of innovation in health care in Europe

17 January 2020 - Pragmatic or practice-oriented comparative effectiveness trials may be conducted to fill the evidence gaps that are revealed ...

Read more →

Government to invest £16 million in 'life-saving' medical advances

22 July 2019 - The Government has announced the decision to invest around £16 million in various ‘life-saving’ medical advances, ...

Read more →

Economic analysis falls short when it comes to medicines’ value

26 February 2019 - For the past two decades, a plethora of organisations identified by various innocuous acronyms (e.g., NICE) ...

Read more →